These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10770552)

  • 1. The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy.
    Melvin DC; Lee JK; Belsey E; Arnold J; Murphy RL
    AIDS; 2000 Mar; 14(4):463-5. PubMed ID: 10770552
    [No Abstract]   [Full Text] [Related]  

  • 2. Can HCV affect the efficacy of anti-HIV treatment?
    Filippini P; Coppola N; Scolastico C; Liorre G; Nocera R; Sagnelli E; Piccinino F
    Arch Virol; 2000; 145(5):937-44. PubMed ID: 10881680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.
    den Brinker M; Wit FW; Wertheim-van Dillen PM; Jurriaans S; Weel J; van Leeuwen R; Pakker NG; Reiss P; Danner SA; Weverling GJ; Lange JM
    AIDS; 2000 Dec; 14(18):2895-902. PubMed ID: 11153671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of liver enzymes in an HIV-hepatitis C virus-co-infected patient after potent antiretroviral therapy.
    Diaz B; Martín-Carbonero L; Pérez-Olmeda M; Soriano V
    AIDS; 2002 May; 16(8):1193. PubMed ID: 12004283
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV and hepatitis C virus co-infection.
    Sulkowski M
    Hopkins HIV Rep; 1998 Nov; 10(6):8, 12. PubMed ID: 11366132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
    Torti C; Lapadula G; Casari S; Puoti M; Nelson M; Quiros-Roldan E; Bella D; Pastore G; Ladisa N; Minoli L; Sotgiu G; Mazzotta F; Lo Caputo S; Di Perri G; Filice G; Tinelli C; Carosi G;
    BMC Infect Dis; 2005 Jul; 5():58. PubMed ID: 16018804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver enzymes elevation after HAART in HIV-HCV co-infection.
    Servin-Abad L; Molina E; Baracco G; Arosemena L; Regev A; Jeffers L; Schiff E
    J Viral Hepat; 2005 Jul; 12(4):429-34. PubMed ID: 15985015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
    Mehta SH; Thomas DL; Torbenson M; Brinkley S; Mirel L; Chaisson RE; Moore RD; Sulkowski MS
    Hepatology; 2005 Jan; 41(1):123-31. PubMed ID: 15619237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent transaminitis induced by oral contraceptives during HIV infection.
    Loulergue P; Coriat R; Mir O
    Ann Pharmacother; 2015 Feb; 49(2):258-9. PubMed ID: 25583940
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.
    Sulkowski MS; Thomas DL; Mehta SH; Chaisson RE; Moore RD
    Hepatology; 2002 Jan; 35(1):182-9. PubMed ID: 11786975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
    Ingiliz P; Valantin MA; Duvivier C; Medja F; Dominguez S; Charlotte F; Tubiana R; Poynard T; Katlama C; Lombès A; Benhamou Y
    Hepatology; 2009 Feb; 49(2):436-42. PubMed ID: 19085967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].
    Gavazzi G; Richallet G; Morand P; Bouchard O; Bosseray A; Leclercq P; Micoud M
    Pathol Biol (Paris); 1998 Jun; 46(6):412-5. PubMed ID: 9769871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing antiretroviral therapy for HCV coinfected people.
    Swan T
    GMHC Treat Issues; 2006; 20(4-7):9-11. PubMed ID: 17228450
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of statin therapy in HIV/hepatitis C virus-coinfected patients.
    Milazzo L; Menzaghi B; Corvasce S; Bonfanti P; Rusconi S; Ridolfo AL; Antinori S
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):258-60. PubMed ID: 17895771
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver transplantation in a patient coinfected with human immunodeficiency virus and hepatitis C virus.
    González Alonso R; Bárcena R; Blesa C; Garcia M; Moreno A; Fortun J; Martin P; Quereda C; de Vicente E
    Transplant Proc; 2003 Aug; 35(5):1846-7. PubMed ID: 12962819
    [No Abstract]   [Full Text] [Related]  

  • 16. First things first: balancing hepatitis C and human immunodeficiency virus.
    Graham CS; Koziel MJ
    Clin Infect Dis; 2003 Feb; 36(3):368-9. PubMed ID: 12539080
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
    Neukam K; Mira JA; Ruiz-Morales J; Rivero A; Collado A; Torres-Cornejo A; Merino D; de Los Santos-Gil I; Macías J; González-Serrano M; Camacho A; Parra-García G; Pineda JA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2605-14. PubMed ID: 21903660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal Cohort.
    Sibiude J; Warszawski J; Tubiana R; Le Chenadec J; Meier F; Faye A; Blanche S; Mandelbrot L;
    J Acquir Immune Defic Syndr; 2019 May; 81(1):83-94. PubMed ID: 30702449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection.
    French AL; Benning L; Anastos K; Augenbraun M; Nowicki M; Sathasivam K; Terrault NA
    Clin Infect Dis; 2004 Aug; 39(3):402-10. PubMed ID: 15307009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.